HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electrophysiological characteristic of a patient exhibiting the short-coupled variant of torsade de pointes.

Abstract
A 41-year-old man was admitted because of syncope. The electrocardiogram showed torsade de pointes (Tdp) with no long QT interval and the coupling interval of the initial beat of Tdp was 240 ms. Heterogeneity of ventricular refractoriness was observed together with shortness of the effective refractory period measured at the right ventricular inflow site where the paced QRS morphology was the same as that of the initial beat of Tdp. Verapamil could suppress frequent ventricular premature complexes with a short coupling interval, which lead to Tdp. Polymorphic ventricular tachycardia was induced by triple ventricular extrastimuli. A pure potassium channel blocker was successful in inhibiting polymorphic ventricular tachycardia inducibility by prolongation of refractoriness. These results suggested that triggered ventricular premature complexes may be represent the initiating mechanism, whereas the shortness of local refractory period and heterogeneity of ventricular refractoriness may play a role in the development and the maintenance of the Tdp.
AuthorsT Shiga, M Shoda, N Matsuda, Y Fuda, N Hagiwara, S Ohnishi, A Watanabe, H Kasanuki
JournalJournal of electrocardiology (J Electrocardiol) Vol. 34 Issue 3 Pg. 271-5 (Jul 2001) ISSN: 0022-0736 [Print] United States
PMID11455519 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
Topics
  • Adult
  • Anti-Arrhythmia Agents (pharmacology)
  • Electrocardiography
  • Electrophysiologic Techniques, Cardiac
  • Heart Conduction System (physiopathology)
  • Humans
  • Male
  • Torsades de Pointes (diagnosis, physiopathology)
  • Ventricular Premature Complexes (diagnosis, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: